Is Sangani Hospital overvalued or undervalued?

As of 19 November 2025, Sangani Hospital's valuation grade has moved from fair to attractive, indicating a positive shift in its perceived value. The company is currently assessed as undervalued, particularly in comparison to its peers. Key financial ratios include a price-to-earnings (PE) ratio of 35.77, an EV to EBITDA ratio of 35.00, and a return on equity (ROE) of 6.98%.
When compared to peers, Sangani Hospital's PE ratio is significantly lower than that of Max Healthcare, which stands at 80.06, and Narayana Hrudaya at 47.55, both categorized as expensive. In contrast, Apollo Hospitals, also rated attractive, has a PE ratio of 64.09, further supporting the notion that Sangani Hospital is undervalued. Despite a year-to-date stock return of -7.75% compared to the Sensex's 10.18%, the current valuation suggests that there is potential for recovery and growth in the company's stock price.